Changing trends in the surgical treatment of Ménière's disease: results of a 10-year survey.
In order to discern trends in surgical procedures used to treat Ménière's disease in the United States during the 1990s, we mailed a questionnaire to 700 members of the American Otological Society and the American Neurotology Society. These physicians were asked about the frequency, results, and complications of surgical procedures for Ménière's disease that they had performed between Jan. 1, 1990, and Dec. 31, 1999. Questionnaires were returned by 137 surgeons (19.6%). Their responses indicated that the number of vestibular neurectomies, labyrinthectomies, and endolymphatic sac surgeries all decreased during 1999. Meanwhile, the use of office-administered intratympanic gentamicin therapy increased rapidly throughout the entire 10-year period, and by 1999 it had become the most frequently used invasive treatment for Ménière's disease. Surgeons now seem to reserve inpatient procedures for cases where intratympanic gentamicin fails to control vertigo.
Silverstein
Herbert
H
Ear Research Foundation, Sarasota, Fla., USA. hsilverstein@aol.com
Lewis
William B
WB
Jackson
Lance E
LE
Rosenberg
Seth I
SI
Thompson
Jack H
JH
Hoffmann
Karen K
KK
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D007758:Ear, Inner / Q000601:surgery; D004712:Endolymphatic Sac / Q000601:surgery; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D008575:Meniere Disease / Q000601:surgery*; D013506:Otologic Surgical Procedures / Q000639:trends*; D010818:Practice Patterns, Physicians' / Q000639:trends*; D016896:Treatment Outcome; D014722:Vestibule, Labyrinth / Q000601:surgery
D000900:Anti-Bacterial Agents; D005839:Gentamicins